Lariba, Baby Girl .

HRN: 28-79-93  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/11/2026
04/18/2026
IV
52mg
Q24h
PSNB
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: